Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating the substance-abusing suicidal patient.

J R Cornelius1, I M Salloum, K Lynch

  • 1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA. jcornel@pitt.edu

Annals of the New York Academy of Sciences
|June 20, 2001
PubMed
Summary

Treatment for suicidal patients with substance abuse issues is limited. Fluoxetine showed promise in reducing depression, suicidal thoughts, and alcohol use, with benefits persisting for a year, though further research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adolescent Binge Drinking Is Associated With Accelerated Decline of Gray Matter Volume.

Cerebral cortex (New York, N.Y. : 1991)·2021
Same author

Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) study.

Drug and alcohol dependence·2021
Same author

Baseline brain function in the preadolescents of the ABCD Study.

Nature neuroscience·2021
Same author

Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2019
Same author

Charting a Course for Implementation Research in Oral Health.

JDR clinical and translational research·2019
Same author

Antidepressant medication exposure and 5-HT<sub>1A</sub> autoreceptor binding in major depressive disorder.

Synapse (New York, N.Y.)·2019

Area of Science:

  • Psychiatry
  • Addiction Medicine
  • Clinical Psychology

Background:

  • Suicidal behavior is common in substance-abusing populations.
  • Optimal treatment strategies for this group remain understudied.
  • Suicidality is often an exclusion criterion in substance abuse treatment research.

Purpose of the Study:

  • To review existing research on treating substance-abusing suicidal patients.
  • To evaluate the efficacy of fluoxetine in this population.
  • To identify factors influencing treatment outcomes.

Main Methods:

  • Review of early open-label trials.
  • Analysis of a double-blind, placebo-controlled study of fluoxetine in patients with comorbid major depressive disorder and alcohol dependence.

Related Experiment Videos

  • Secondary data analyses on smoking, marijuana use, and cocaine abuse.
  • 1-year naturalistic follow-up study.

    • Main Results:

    • Fluoxetine demonstrated significant reductions in depressive symptoms, suicidal ideation, and alcohol consumption.
    • Benefits of fluoxetine persisted at 1-year follow-up.
    • Cocaine abuse predicted poorer outcomes.
    • Fluoxetine also decreased cigarette and marijuana smoking, with robust effects on cannabis abuse.

    Conclusions:

    • Fluoxetine appears effective in managing comorbid depression, suicidality, and substance use in certain patients.
    • Further research is necessary to establish optimal pharmacotherapeutic and psychotherapeutic interventions.
    • Cocaine abuse is a significant negative prognostic factor in this patient group.